Cargando…
Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study
BACKGROUND: Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown. OBJECTIVE: Our aims were to determine the incidence of SARS-CoV-2 infection in households with children and to also determi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155183/ https://www.ncbi.nlm.nih.gov/pubmed/35660376 http://dx.doi.org/10.1016/j.jaci.2022.05.014 |
_version_ | 1784718188201639936 |
---|---|
author | Seibold, Max A. Moore, Camille M. Everman, Jamie L. Williams, Blake J.M. Nolin, James D. Fairbanks-Mahnke, Ana Plender, Elizabeth G. Patel, Bhavika B. Arbes, Samuel J. Bacharier, Leonard B. Bendixsen, Casper G. Calatroni, Agustin Camargo, Carlos A. Dupont, William D. Furuta, Glenn T. Gebretsadik, Tebeb Gruchalla, Rebecca S. Gupta, Ruchi S. Khurana Hershey, Gurjit K. Murrison, Liza Bronner Jackson, Daniel J. Johnson, Christine C. Kattan, Meyer Liu, Andrew H. Lussier, Stephanie J. O’Connor, George T. Rivera-Spoljaric, Katherine Phipatanakul, Wanda Rothenberg, Marc E. Seroogy, Christine M. Teach, Stephen J. Zoratti, Edward M. Togias, Alkis Fulkerson, Patricia C. Hartert, Tina V. |
author_facet | Seibold, Max A. Moore, Camille M. Everman, Jamie L. Williams, Blake J.M. Nolin, James D. Fairbanks-Mahnke, Ana Plender, Elizabeth G. Patel, Bhavika B. Arbes, Samuel J. Bacharier, Leonard B. Bendixsen, Casper G. Calatroni, Agustin Camargo, Carlos A. Dupont, William D. Furuta, Glenn T. Gebretsadik, Tebeb Gruchalla, Rebecca S. Gupta, Ruchi S. Khurana Hershey, Gurjit K. Murrison, Liza Bronner Jackson, Daniel J. Johnson, Christine C. Kattan, Meyer Liu, Andrew H. Lussier, Stephanie J. O’Connor, George T. Rivera-Spoljaric, Katherine Phipatanakul, Wanda Rothenberg, Marc E. Seroogy, Christine M. Teach, Stephen J. Zoratti, Edward M. Togias, Alkis Fulkerson, Patricia C. Hartert, Tina V. |
author_sort | Seibold, Max A. |
collection | PubMed |
description | BACKGROUND: Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown. OBJECTIVE: Our aims were to determine the incidence of SARS-CoV-2 infection in households with children and to also determine whether self-reported asthma and/or other allergic diseases are associated with infection and household transmission. METHODS: For 6 months, biweekly nasal swabs and weekly surveys were conducted within 1394 households (N = 4142 participants) to identify incident SARS-CoV-2 infections from May 2020 to February 2021, which was the pandemic period largely before a vaccine and before the emergence of SARS-CoV-2 variants. Participant and household infection and household transmission probabilities were calculated by using time-to-event analyses, and factors associated with infection and transmission risk were determined by using regression analyses. RESULTS: In all, 147 households (261 participants) tested positive for SARS-CoV-2. The household SARS-CoV-2 infection probability was 25.8%; the participant infection probability was similar for children (14.0% [95% CI = 8.0%-19.6%]), teenagers (12.1% [95% CI = 8.2%-15.9%]), and adults (14.0% [95% CI = 9.5%-18.4%]). Infections were symptomatic in 24.5% of children, 41.2% of teenagers, and 62.5% of adults. Self-reported doctor-diagnosed asthma was not a risk factor for infection (adjusted hazard ratio [aHR] = 1.04 [95% CI = 0.73-1.46]), nor was upper respiratory allergy or eczema. Self-reported doctor-diagnosed food allergy was associated with lower infection risk (aHR = 0.50 [95% CI = 0.32-0.81]); higher body mass index was associated with increased infection risk (aHR per 10-point increase = 1.09 [95% CI = 1.03-1.15]). The household secondary attack rate was 57.7%. Asthma was not associated with household transmission, but transmission was lower in households with food allergy (adjusted odds ratio = 0.43 [95% CI = 0.19-0.96]; P = .04). CONCLUSION: Asthma does not increase the risk of SARS-CoV-2 infection. Food allergy is associated with lower infection risk, whereas body mass index is associated with increased infection risk. Understanding how these factors modify infection risk may offer new avenues for preventing infection. |
format | Online Article Text |
id | pubmed-9155183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-91551832022-06-02 Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study Seibold, Max A. Moore, Camille M. Everman, Jamie L. Williams, Blake J.M. Nolin, James D. Fairbanks-Mahnke, Ana Plender, Elizabeth G. Patel, Bhavika B. Arbes, Samuel J. Bacharier, Leonard B. Bendixsen, Casper G. Calatroni, Agustin Camargo, Carlos A. Dupont, William D. Furuta, Glenn T. Gebretsadik, Tebeb Gruchalla, Rebecca S. Gupta, Ruchi S. Khurana Hershey, Gurjit K. Murrison, Liza Bronner Jackson, Daniel J. Johnson, Christine C. Kattan, Meyer Liu, Andrew H. Lussier, Stephanie J. O’Connor, George T. Rivera-Spoljaric, Katherine Phipatanakul, Wanda Rothenberg, Marc E. Seroogy, Christine M. Teach, Stephen J. Zoratti, Edward M. Togias, Alkis Fulkerson, Patricia C. Hartert, Tina V. J Allergy Clin Immunol Covid-19 BACKGROUND: Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown. OBJECTIVE: Our aims were to determine the incidence of SARS-CoV-2 infection in households with children and to also determine whether self-reported asthma and/or other allergic diseases are associated with infection and household transmission. METHODS: For 6 months, biweekly nasal swabs and weekly surveys were conducted within 1394 households (N = 4142 participants) to identify incident SARS-CoV-2 infections from May 2020 to February 2021, which was the pandemic period largely before a vaccine and before the emergence of SARS-CoV-2 variants. Participant and household infection and household transmission probabilities were calculated by using time-to-event analyses, and factors associated with infection and transmission risk were determined by using regression analyses. RESULTS: In all, 147 households (261 participants) tested positive for SARS-CoV-2. The household SARS-CoV-2 infection probability was 25.8%; the participant infection probability was similar for children (14.0% [95% CI = 8.0%-19.6%]), teenagers (12.1% [95% CI = 8.2%-15.9%]), and adults (14.0% [95% CI = 9.5%-18.4%]). Infections were symptomatic in 24.5% of children, 41.2% of teenagers, and 62.5% of adults. Self-reported doctor-diagnosed asthma was not a risk factor for infection (adjusted hazard ratio [aHR] = 1.04 [95% CI = 0.73-1.46]), nor was upper respiratory allergy or eczema. Self-reported doctor-diagnosed food allergy was associated with lower infection risk (aHR = 0.50 [95% CI = 0.32-0.81]); higher body mass index was associated with increased infection risk (aHR per 10-point increase = 1.09 [95% CI = 1.03-1.15]). The household secondary attack rate was 57.7%. Asthma was not associated with household transmission, but transmission was lower in households with food allergy (adjusted odds ratio = 0.43 [95% CI = 0.19-0.96]; P = .04). CONCLUSION: Asthma does not increase the risk of SARS-CoV-2 infection. Food allergy is associated with lower infection risk, whereas body mass index is associated with increased infection risk. Understanding how these factors modify infection risk may offer new avenues for preventing infection. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology 2022-08 2022-06-01 /pmc/articles/PMC9155183/ /pubmed/35660376 http://dx.doi.org/10.1016/j.jaci.2022.05.014 Text en © 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Covid-19 Seibold, Max A. Moore, Camille M. Everman, Jamie L. Williams, Blake J.M. Nolin, James D. Fairbanks-Mahnke, Ana Plender, Elizabeth G. Patel, Bhavika B. Arbes, Samuel J. Bacharier, Leonard B. Bendixsen, Casper G. Calatroni, Agustin Camargo, Carlos A. Dupont, William D. Furuta, Glenn T. Gebretsadik, Tebeb Gruchalla, Rebecca S. Gupta, Ruchi S. Khurana Hershey, Gurjit K. Murrison, Liza Bronner Jackson, Daniel J. Johnson, Christine C. Kattan, Meyer Liu, Andrew H. Lussier, Stephanie J. O’Connor, George T. Rivera-Spoljaric, Katherine Phipatanakul, Wanda Rothenberg, Marc E. Seroogy, Christine M. Teach, Stephen J. Zoratti, Edward M. Togias, Alkis Fulkerson, Patricia C. Hartert, Tina V. Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study |
title | Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study |
title_full | Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study |
title_fullStr | Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study |
title_full_unstemmed | Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study |
title_short | Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study |
title_sort | risk factors for sars-cov-2 infection and transmission in households with children with asthma and allergy: a prospective surveillance study |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155183/ https://www.ncbi.nlm.nih.gov/pubmed/35660376 http://dx.doi.org/10.1016/j.jaci.2022.05.014 |
work_keys_str_mv | AT seiboldmaxa riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT moorecamillem riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT evermanjamiel riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT williamsblakejm riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT nolinjamesd riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT fairbanksmahnkeana riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT plenderelizabethg riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT patelbhavikab riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT arbessamuelj riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT bacharierleonardb riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT bendixsencasperg riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT calatroniagustin riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT camargocarlosa riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT dupontwilliamd riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT furutaglennt riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT gebretsadiktebeb riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT gruchallarebeccas riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT guptaruchis riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT khuranahersheygurjitk riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT murrisonlizabronner riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT jacksondanielj riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT johnsonchristinec riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT kattanmeyer riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT liuandrewh riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT lussierstephaniej riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT oconnorgeorget riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT riveraspoljarickatherine riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT phipatanakulwanda riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT rothenbergmarce riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT seroogychristinem riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT teachstephenj riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT zorattiedwardm riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT togiasalkis riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT fulkersonpatriciac riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT harterttinav riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy AT riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy |